Neuromuscular Disorders

Papers
(The H4-Index of Neuromuscular Disorders is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
P.174 TRIM32 related muscular dystrophy mimicking inflammatory myopathy: Clinical and histopathological features in two siblings67
P137 Prophylactic use of cardiac medications and prolonged survival in Duchenne muscular dystrophy52
P.77 Clinical presentation of two Korean patients with adolescent-onset very-long-chain acyl-CoA dehydrogenase deficiency49
P.53 Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients48
DMD – ANIMAL MODELS44
P.17 Importance of routine pulmonary check-up prior to ventilatory support in patients with Duchenne muscular dystrophy41
P.30 Correlation of histopathological skeletal muscle biopsy features with quantitative muscle-MRI parameters40
P145 Analysis of the natural evolution of SV95C in ambulant patients with Duchenne muscular dystrophy38
P61 High dose localized muscle irradiation: Hedgehog pathway as a new therapeutic target35
P.224 Non-5q spinal muscular atrophy in twin sisters with SPG11/CMT2X associated spatacsin gene mutation34
P33 RKER-065 ameliorated muscle and bone loss in a progressive murine model of Duchenne muscular dystrophy31
P443 A case of Charcot-Marie-Tooth Type 4F31
P295 Functional improvements by ataluren in dysferlinopathy mice with a compound heterozygous mutations carrying one nonsense variant31
P311 Facioscapulohumeral muscular dystrophy European patient survey: assessing patient preferences in clinical trial participation 29
INV09 Novel repeat disorders in muscle disease: the emergence of OPDM28
P154 The generation of a GNE myopathy patient-derived biobank enables the study of disease-relevant cellular phenotypes across multiple pathogenic variants27
P164 Development of a myotube model for C-terminal titin studies26
P251 Vamorolone improves Becker muscular dystrophy and increases dystrophin protein in novel bmx model mice25
SMA - TREATMENT24
SMA - TREATMENT24
APPLICATION OF NEXT GENERATION TECHNOLOGIES21
A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review21
WMS General Information21
0.06194806098938